Ken is currently the Managing Partner/CEO of Lightstone Singapore Pte. Ltd (LSV(SG); an early stage life sciences venture fund focused on commercializing innovative technologies found in or imported into the Singapore life science ecosystem. Prior to the formation of LSV(SG) Ken was a Venture Partner at Advanced Technology Ventures (ATV); one of the predecessor funds to Lightstone Ventures.
Earlier in his career Ken was, for 15 years, a Senior Partner at L.E.K. Consulting where he managed the European Life Sciences Practice. Ken joined L.E.K. from Booz-Allen & Hamilton’s European Life Sciences Practice. Prior to joining BAH, Ken was the Managing Director of The Wilkerson Group Ltd.; the European arm of The Wilkerson Group Inc., a boutique strategy consulting firm dedicated to the various life science industries.
Ken has also held a series of operating roles in established research products and in vitro diagnostic companies.
Ken has a Ph.D. in Biochemistry from Princeton University.